Long-acting injectable cabotegravir for PrEP: A game-changer in HIV prevention?
Geoffroy LiegeonJade GhosnPublished in: HIV medicine (2022)
CAB-LA has not yet achieved its full potential in HIV prevention, and strong commitment from all stakeholders is required to push CAB-LA as a game-changer in HIV response.